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ABSTRACT 
 
Background: Effective glucose management using exercise modalities in older patients 
with type 2 diabetes and activities of daily living (ADL) disabilities are unknown.   
Purpose: The study investigated the acute effects of motor-assisted cycling and functional 
electrical stimulation (FES) cycling on the 2-h postprandial glucose responses compared 
with sitting control in older adults with type 2 diabetes and ADL disabilities. 
Methods: The study used a 3×3 crossover study design. Nine participants were randomly 
assigned to one of the three treatment sequences: ABC, BCA, and CAB. (A, motor-assisted 
cycling; B, FES cycling; C, sitting control). Linear mixed models (LMM) with Bonferroni 
post-hoc tests were used to test the mean differences for the 2-h postprandial glucose, 
estimated by the area under the curve (AUC) and incremental AUC (iAUC), between 
intervention and control treatments after adjustment for covariates (e.g., age, sex, and 
race).   
Results: There were significant mean differences for iAUC (p = 0.005) and AUC (p = 
0.038) across motor-assisted cycling, control, and FES cycling treatments. The FES 
cycling had a lower mean of 2-hour postprandial iAUC as compared with sitting control 
(iAUC 3.98 mmol∙h/L vs 6.92 mmol∙h/L, p = 0.006, effect size [ES] = 1.72) and the 
motor-assisted cycling (iAUC, 3.98 mmol∙h/L vs 6.19 mmol∙h/L , p = 0.0368, ES = 1.29), 
respectively. The FES cycling also had a lower mean of the 2-hour postprandial AUC as 
compared with sitting control (AUC, 18.29 mmol∙h/L vs 20.95 mmol∙h/L, p = 0.043, ES 
= 0.89), but had an AUC similar to the motor-assisted cycling (18.29 mmol∙h/L vs 20.23 
mmol∙h/L , p = 0.183, ES = 0.19). There were no statistical differences in iAUC (6.19 
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mmol∙h/L vs 6.92 mmol∙h/L) and AUC (20.23 mmol∙h/L vs 20.95 mmol∙h/L) between 
the motor-assisted cycling and sitting control (all p>0.05). 
Conclusion: Performing 30 minutes of FES cycling on a motor-assisted bike (40 Hz, 39 
rpm, 25-29 mA) significantly decreased the 2-h postprandial glucose levels in older 
adults with type 2 diabetes and ADL disabilities. These findings suggested that FES 
cycling can be a promising exercise modality for glucose management in diabetic patients 
with ADL disabilities.   
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CHAPTER 1 
INTRODUCTION 
Background    
Type 2 diabetes is a significant risk factor for cardiovascular diseases and all-
cause mortality (Grundy et al., 1999). Approximately 30.3 million American adults suffer 
from diabetes (Centers for Disease Control and Prevention [CDC], 2017). Of these, about 
23.8% are undiagnosed (CDC, 2017). Since diabetes requires lifetime care, secondary 
prevention of diabetic complications is essential to alleviate the burden of this disease. 
Estimated medical costs associated with diabetes in the United States (US) is about $176 
billion a year (American Diabetes Association [ADA], 2013). If the current rising trend 
of diabetes continues, one in three Americans will have diabetes by 2050 (Boyle, 
Thompson, Gregg, Barker, & Williamson, 2010). As a diabetes prevention strategy, the 
American Diabetes Association recommends lifestyle modifications and promotes a 
healthy diet and regular exercise (ADA, 2013). However, the specific exercise 
recommendations for individuals with diabetes and activities of daily living (ADL) 
disabilities remains less clear.  
Diabetes & Aging 
Type 2 diabetes is a growing epidemic in the US, especially among the elderly 
population. The latest national diabetes statistics issued by the CDC showed that about 
25.2% of the older adults (≥ 65 years) had diabetes (CDC, 2017). Also, it has been 
estimated that approximately 12 million people aged 65 years or older had diabetes in the 
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US, accounting for 40% of total diabetes cases in adults (CDC, 2017). In this age group, 
most diabetes cases were type 2 diabetes. According to the National Health and Nutrition 
Examination Survey (NHANES 1999-2000), the prevalence of type 1 diabetes was 
approximately 0.1% in persons ≥ 60 years old (Menke et al., 2013). 
Diabetes & Disability 
Older adults with diabetes are at high risk of developing disabilities, including 
ADL disability (Wong et al., 2013). According to the World Health Organization 
(WHO), disability is a broad concept that covers functional impairment and activity 
limitations (WHO, 2001). The ADL disability is defined as difficult or inability to 
perform ADLs, such as transferring from bed to chair, using the toilet, or bathing, etc. 
(Guralnik et al., 1994).  
The prevalence of disability in older adults with diabetes is staggering and 
requires further attention. Gregg et al. (2000) have reported that the prevalence of 
mobility disability in elderly diabetic patients (aged >60 years) was 63.4% % in women 
and 39.2% in men. Other investigators have shown that the prevalence of ADL 
disabilities in older diabetic patients (aged >60 years) was 37.2% (Kalyani, Saudek, 
Brancati, & Selvin, 2010).   
The mechanism underlying the association between diabetes and disability 
involves multiple factors, including diabetic complications and comorbidities (Gregg & 
Menke, 2017). Based on the National Health Interview Survey 2010 data, Gregg and 
Menke (2017) reported that arthritis was the most common cause of disability in patients 
with diabetes. Approximately 35% to 44% of diabetic patients with disabilities reported 
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arthritis as the cause (Gregg & Menke, 2017). Type 2 diabetes has been associated with 
both osteoarthritis and rheumatoid arthritis (Albrecht, Luque Ramos, Hoffmann, Redeker, 
& Zink, 2017; Nielen et al., 2018), both of which can directly cause joint pain and 
impairment of lower-extremity function. Other investigators (Jude, Oyibo, Chalmers, & 
Boulton, 2001; Volpato et al., 2003) have also shown that peripheral artery disease 
(PAD) and peripheral neuropathy (PND) were the most important factors for disability. 
Patients with diabetes are susceptible to PAD, a well-known condition that can cause pain 
during ambulation. The PND is a common diabetic complication, which occurs in up to 
50% of older patients (Boulton, 2005). The PND can cause severe pain and weakness in 
the lower extremities, leading to a decline in mobility, gait, and balance (Boulton, 2005).  
Exercise & Diabetes 
Exercise has been considered as one of the cornerstones of diabetes management 
(ADA, 2017). Compelling evidence indicates that exercise is effective in reducing the 
incidence of diabetes (Diabetes Prevention Program Research Group, 2002), optimizing 
glycemic control (Umpierre et al., 2011), improving cardiovascular health (Boulé, 
Kenny, Haddad, Wells, & Sigal, 2003), and reducing overall mortality (Pan et al., 1997). 
Previous studies have shown that 30 to 60 minutes of post-meal exercise could 
significantly lower postprandial glucose in patients with type 2 diabetes (Erickson, Little, 
Gay, Mccully, & Jenkins, 2017a; Erickson, Little, Gay, McCully, & Jenkins, 2017b; 
Larsen, Dela, Kjaer, & Galbo, 1997;Van Dijk et al., 2012; Van Dijk et al., 2013). 
However, there is a paucity of experimental evidence regarding the most appropriate 
exercise modalities that are safe and effective in improving glucose management among 
elderly diabetic patients with ADL disabilities. Previous studies investigating the effects 
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of exercise on diabetes have been focusing on brisk walking and upright cycling (Crespo, 
Mullane, Zeigler, Buman, & Gaesser, 2016; Erickson et al., 2017a; Erickson et al., 
2017b; Gillen et al., 2012; Larsen et al., 1997; Van Dijk et al., 2012; Van Dijk et al., 
2013). Nevertheless, traditional exercise such as brisk walking and upright cycling may 
not be suitable for older patients with ADL disabilities due to their limited exercise 
ability and impaired lower-extremity function. There is a need to investigate alternative 
exercise modalities to support evidence-based exercise prescriptions in this vulnerable 
and rapidly growing population. 
Motor-Assisted Cycling 
Patients with ADL disabilities may experience substantial difficulties in performing 
volitional cycling due to severely impaired lower-extremity function. For this population, 
motor-assisted cycling can be a promising alternative to voluntary exercise. Motor-
assisted cycling has been used an exercise intervention to improve motor control and 
cognitive function in individuals with Down syndrome (Ringenbach, Albert, Chen, & 
Alberts, 2014), improve motor function in stroke survivors (Holzapfel et al., 2019), 
increase energy expenditure in sedentary persons (Peterman, Wright, Melanson, Kram, & 
Byrnes, 2016), and restore muscle strength in immobilized patients (Machado et al., 
2017). The previously reported effects of motor-assisted cycling on energy expenditure 
and blood glucose suggested a potential application of this exercise modality in patients 
with type 2 diabetes. A study in healthy individuals showed that motor-assisted cycling 
increased the oxygen consumption to 1.4 folds at 60 rpm (0.37 L/min vs. 0.27 L/min) and 
1.9 folds at 90 rpm (0.52 L/min vs. 0.27 L/min), as compared with resting oxygen 
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consumption (Peterman, Kram, & Byrnes, 2012). Their outcomes also suggested that 
motor-assisted cycling a high cycling cadence tended to be more effective in increasing 
energy expenditure. Peterman and his associates (2016) showed that 30 minutes of 
motor-assisted cycling at 80 rpm significantly lowered 2-h plasma glucose compared to 
sitting control in overweight or obese persons. The possible mechanism underlying the 
increased energy expenditure during motor-assisted cycling was revealed in a recent 
study. Bell et al. (2003) demonstrated that leg muscle activities were present, as indicated 
by electromyography (Bell et al., 2003) during motor-assisted cycling. It has been well 
accepted that muscle contractions can increase energy expenditure and periphery glucose 
uptake (Ryder, Chibalin, & Zierath, 2001). Therefore, we believe that motor-assisted 
cycling can be a potential exercise modality to lower blood glucose levels in patients with 
type 2 diabetes and ADL disabilities. 
Functional Electrical Stimulation Cycling 
Patients with ADL disability may experience substantial difficulties in performing 
voluntary cycling exercise due to severely impaired lower-extremity function. For this 
population, functional electrical stimulation (FES) cycling can be an alternative exercise 
to benefit glycemic control. FES cycling has been extensively used as a rehabilitation 
therapy in persons with spinal cord injury (SCI) to attenuate muscle atrophy due to long-
term inactivity (Baldi, Jackson, Moraille, & Mysiw, 1998). It has also been used in 
critically ill patients and post-stroke patients to restore physical function (Lee et al., 
2013). Studies have shown that FES cycling can significantly increase energy 
expenditure and decrease postprandial glucose, suggesting a potential application of FES 
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cycling in patients with diabetes and ADL disabilities who may experience difficulty 
performing the traditional exercise. (Griffin et al., 2009; Jeon et al., 2002). 
Statement of the Problem 
Previous studies have shown that motor-assisted cycling and FES cycling are 
effective in decreasing hyperglycemia in various non-diabetic populations, including 
those suffering from stroke (Lee et al., 2013) or SCI (Griffin et al., 2009; Jeon et al., 
2002). However, there is a paucity of evidence regarding the effects of these alternative 
exercise modalities on hyperglycemia in patients with type 2 diabetes and ADL 
disability. Therefore, the purpose of this study is to investigate the effects of motor-
assisted cycling and FES cycling on postprandial glucose in type 2 diabetic patients with 
ADL disability. The study has two specific aims and hypotheses: 
Aims and Hypotheses 
Aim 1: To investigate the acute effect of motor-assisted cycling (3×10-min bouts) 
on postprandial glucose in older adults with type 2 diabetes and ADL disabilities. We 
hypothesize that the accumulated 30 minutes of post-meal motor-assisted cycling is 
sufficient to lower postprandial glucose estimated by the area under the curve (AUC) and 
incremental AUC (iAUC), as compared with sitting control. 
Aim 2: To investigate the effect of FES cycling on a motor-assisted bike (3×10-
min bouts) on postprandial glucose in older adults with type 2 diabetes and ADL 
disabilities. We hypothesize that the accumulated 30 minutes of post-meal FES cycling is 
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sufficient to lower postprandial glucose estimated by AUC and iAUC, as compared with 
sitting control.  
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CHAPTER 2 
LITERATURE REVIEW 
The goals of this study were to determine the effective treatments for glycemic 
control for those diabetic patients who suffer from ADL disabilities. The literature review 
focused on diabetes pathology and complications (the natural history of diabetes and its 
health consequences), methods for assessing study outcomes, effect of exercise on 
postprandial glucose, safety considerations of exercise in the older patients with diabetes, 
and potential benefits of the two exercise modalities (i.e., motor-assisted cycling and FES 
cycling) on blood glucose levels. 
 
Overview of Diabetes Pathology 
Type 2 Diabetes Mellitus Pathogenesis 
Diabetes is a metabolic disease that is featured by sustained hyperglycemia. There 
are four main categories of diabetes, including type 1 diabetes, type 2 diabetes, 
gestational diabetes, and other types of diabetes, such as monogenic diabetes and cystic 
fibrosis-related diabetes. Type 2 diabetes mellitus has been the most common type, 
accounting for 90-95% of total diabetes cases (CDC, 2017). The pathogenesis of type 2 
diabetes involves the development of insulin resistance and progressive pancreatic beta-
cell dysfunction. Insulin resistance refers to the impaired glucose uptake in response to 
insulin in muscle, fat, and liver cells. In insulin-sensitive persons, the binding of insulin 
to its receptor, insulin receptor tyrosine kinase, activates the downstream signaling 
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cascade, which finally results in the inhibition of hepatic glucose output and the increased 
glucose uptake at periphery tissue (e.g., muscle and adipose cells) (Samuel & Shulman, 
2012). In this process, both glycogenolysis and gluconeogenesis are inhibited by insulin, 
causing a decrease in hepatic glucose production. Notably, glucose transporter 2 
(GLUT2), which is responsible for the glucose release in the liver, is insulin-independent, 
indicating that GLUT2 is not a major regulatory point for the effect of insulin on glucose 
(Nordlie, Foster, & Lange, 1999). In contrast, glucose transporter type 4 (GLUT4), which 
is responsible for the glucose uptake in peripheral tissues, is insulin-responsive. It 
functions as a major regulatory point of the increased glucose uptake due to high levels of 
insulin. The insulin recruits the translocation of GLUT4 to the cell surface and enhances 
the activity of GLUT4 (Watson & Pessin, 2001). This important mechanism of peripheral 
glucose uptake is impaired in insulin-resistant persons due to defects in insulin signaling, 
although the GLUT4 concentration remains normal (Holten et al., 2004). Specifically, the 
accumulation of diacylglycerol in muscle tissue activates the novel protein kinase C 
(nPKC), which inhibits the translocation of GLUT4-containing storage vesicles (GSVs) 
and results in the impairment of glucose uptake. In the liver, intrahepatic lipid 
accumulation is primarily responsible for the hepatic insulin resistance (Birkenfeld & 
Shulman, 2014). Lipids in the liver can undermine hepatic insulin sensitivity through 
multiple pathways. For example, diacylglycerol activates PKCε, which increases 
gluconeogenesis through the inhibition of serine/threonine kinase (Akt2), and subsequent 
Forkhead box protein O1 (FOXO1). Akt2 is a kinase that regulates glucose uptake. 
FOXO1 is a transcription factor that regulates gluconeogenesis. Meanwhile, the glycogen 
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synthesis is also suppressed through the inhibition of Akt2, which contributes to the 
hepatic insulin resistance (Samuel & Shulman, 2012). 
The other important pathophysiology process of type 2 diabetes is the progressive 
loss of pancreatic beta-cell function. Although the relative contributions of insulin 
resistance and beta-cell dysfunction are debatable, there has been a consensus that both 
are present at a very early stage, long before the onset of overt diabetes. The early-
appearing dysfunction of beta-cells is manifested in the loss of the first-phase insulin 
secretion, which typically occurs during the first 10–15 min after the administration of 
glucose. The first-phase insulin secretion is crucial for the suppression of hepatic glucose 
production and the maintenance of glucose homeostasis at postprandial state (Del Prato & 
Tiengo, 2001; Luzi & DeFronzo, 1989). Along with the natural history of type 2 diabetes, 
the number of beta-cells decreases continuously, and the function of the remaining cells 
is inhibited, which contributes to the exacerbation of hyperglycemia (Taylor, 2013). 
Risk Factors for Type 2 Diabetes 
The main risk factors for developing diabetes include an age of 45 or older, 
family history of diabetes, obesity, physical inactivity, gestational diabetes, giving birth 
to a baby weighing 9 pounds or more, certain ethnicity (e.g. African American, Alaska 
Native etc.), hypertension, dyslipidemia, depression, polycystic ovary syndrome etc.  
Age is positively associated with the risk of type 2 diabetes. The risk of diabetes 
is roughly 4 times higher in persons aged 45-64, and 6 times higher in persons aged 65 or 
older when compared with persons aged 18-44 years. Specifically, among people ≥ 65 
years old, the prevalence of diabetes is 25.2%, while the pevalence is 17.0% for adults 
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age 45-64 years and 4.0% for adults age 18-44 years (CDC, 2017). Notably, the 
prevalence of type 2 diabetes has also been increasing among children and adolescents 
(Dabelea et al., 2014).  
A cross-sectional study showed that physical inactivity caused up to 18% of type 
2 diabetes cases worldwide (Lee et al., 2012). Also, a prospective cohort study found a 
positive association between TV watching time and the incidence of type 2 diabetes, 
showing that sedentary behavior is a diabetes risk factor (Hu, Li, Colditz, Willett, & 
Manson, 2012). That study also pointed out that 43% of diabetes can be prevented by 
spending less time watching TV and performing 30-minutes of brisk walking every day.  
Compelling evidence supports a strong association between obesity and diabetes. 
Some scientists hold the viewpoint that the association is causal (Lazar, 2005), since 
numerous studies have linked obesity with insulin resistance and diabetes with molecular 
mechanism and biological pathways (e.g., adipocyte-derived free fatty acids, 
inflammation, leptin, etc.) (Dandona, Aljada, & Bandyopadhyay, 2004; Lazar, 2005). 
Prediabetes 
Currently, one in three American adults has prediabetes (CDC, 2014). Prediabetes 
is the leading risk factor for the future development of diabetes (Grundy, 2012). In 
general, up to 70% of persons with prediabetes will develop diabetes over their lifetime, 
with a yearly diabetes incidence of 5-10% (Tabák, Herder, Rathmann, Brunner, & 
Kivimäki, 2012). The definition of prediabetes refers to impaired fasting glucose (IFG) 
and impaired glucose tolerance (IGT). People are considered as having prediabetes if 
they meet at least one of the three diagnostic tests: 1) fasting plasma glucose (FPG) of 
12 
 
100 mg/dL (5.6 mmol/L) to 126 mg/dL (7 mmol/L) implies IFG; 2) 2-h plasma glucose 
(2-h PG) of 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11 mmol/L) implies IGT; 3) HbA1c 
of 5.7% to 6.4% (ADA, 2017). The International Diabetes Federation (IDF) adopted the 
same diagnostic criteria as the ADA did but used the term “intermediate hyperglycemia” 
to describe this high-risk state. IFG is associated with hepatic insulin resistance and 
impairment of first-phase insulin secretion. In contrast, IGT is associated with muscle 
insulin resistance and a severe defect of late-phase insulin secretion (Nathan et al., 2007). 
Notably, for all these diabetes tests, the risk of and cardiovascular diseases (CVD) 
increases continuously along with a higher test value, and an apparent threshold is absent. 
(Gerich, 2003; Stratton et al., 2000). Accordingly, the adverse effect of hyperglycemia on 
the human cardiovascular system begins far before it reaches the diagnostic criteria of 
type 2 diabetes. It has been shown that both IFG and IGT are associated with increased 
CVD risk (Deedwania & Fonseca, 2005). However, multiple studies suggested that the 
individual with IGT carries a greater risk of CVD development than those with IFG 
(DECODE Study Group, 2001; Meigs, Nathan, D’Agostino, & Wilson, 2002; Tominaga 
et al., 1999)  
Complications of Type 2 Diabetes 
Type 2 diabetes can cause both microvascular and macrovascular complications. 
Both microvascular and macrovascular complications have been robustly associated with 
the degree of hyperglycemia. Each 1% reduction in HbA1c levels resulted in a 14% 
reduction in myocardial infarction incidence and a 37 % reduction in microvascular 
complications (Stratton et al., 2000). Diabetic microvascular complications include three 
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diseases: 1) retinopathy, which is the most common microvascular complications and a 
prevailing cause of blindness; 2) nephropathy, which is the leading cause of renal failure; 
3) neuropathy, which is manifested in peripheral nerve dysfunction. The risk of these 
microvascular complications depends on the magnitude and duration of hyperglycemia. 
On the other hand, diabetic macrovascular complications are the cardiovascular 
consequences of atherosclerosis, including coronary artery disease, periphery artery 
disease, and stroke. The prevention of diabetic macrovascular complications entails not 
only glycemic control but also hypertension treatment, lipid reduction, and the cessation 
of smoking (Fowler, 2008). 
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Measuring Blood Glucose and Insulin Sensitivity 
Monitoring Glucose 
HbA1c: The HbA1c test measures the percentage of the hemoglobin that is 
glycated. It reflects the overall glucose control in the past 8-12 weeks.  HbA1c can be 
expressed in percentage and mmol/mol. The ADA also recommends converting the 
HbA1c values in percentage to the estimated average glucose (eAG) in mg/dL using the 
formula, 28.7 × A1c – 46.7 = eAG. Most guidelines recommend a target A1c of <7% for 
the general population. Intensive glucose control that targets an A1c far below 7% can 
increase the risk of hypoglycemia and lead to weight gain.  
Fructosamine and glycated albumin: Both fructosamine and glycated albumin are 
markers that reflect the glucose levels in the past 2-4 weeks. They can be used as 
alternative measures to HbA1c for the short-term intervention studies, in which HbA1c 
changes may be undetectable. A study has shown that fructosamine and glycated albumin 
can provide comparable prognostic performance to predict the incidence of diabetes and 
diabetic microvascular complications (Selvin et al., 2014). 
Fasting plasma glucose (FPG) and postprandial plasma glucose (PPG): FPG and 
PPG are established measures of circulating glucose levels at different metabolic status. 
However, they are susceptible to daily variance due to the acute effects of diet, physical 
activity, and medications before the tests. Notably, PPG is the primary contributor to 
overall diurnal hyperglycemia in patients with HbA1c ≤ 7.3%, while FPG is the main 
contributor among patients with poorly controlled hyperglycemia (Monnier, Lapinski, & 
Colette, 2003). 
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Postprandial glucose contributes substantially (up to 70%) to the overall 
hyperglycemia, as measured by glycated hemoglobin (HbA1c) levels in patients with 
type 2 diabetes (Monnier, Colette, Monnier, & Colette, 2006; Monnier et al., 2003). 
Epidemiological studies have shown that postprandial glucose is associated with the risk 
of macrovascular complications in patients with type 2 diabetes (Bonora & Muggeo, 
2001). Other studies identified postprandial glucose as a direct and independent 
contributor to atherogenesis and CVD (Ceriello, 2005; Gerich, 2003).  Additionally, 
experimental studies revealed that treatments that targeted postprandial glucose achieved 
a greater reduction in HbA1c, as compared with treatments that targeted either pre-meal 
glucose or fasting glucose (Bastyr et al., 2000). Several investigators (Ceriello et al., 
1999; Ceriello, 2005) have also reported the importance of biological mechanisms in 
managing postprandial hyperglycemia. Multiple labs have reported that the acute glucose 
excursions during postprandial glucose resulted in impaired endothelial function and 
increased oxidative stress (Ceriello et al., 1999; Ceriello, 2005) 
Continuous glucose monitoring (CGM): CGM has attracted extensive interest in 
the research field and clinical care of diabetes due to its usefulness and promising 
application in diabetes management. Compared to HbA1c, CGM has two major 
advantages: 1) CGM can detect acute glucose changes, such as hypoglycemic events and 
abnormal postprandial glucose excursions, which enables more accurate and timely 
intervention to avoid severe adverse events. 2) CGM records the dynamics of glucose 
fluctuations daily with and generates visualized data, which can guide personalized 
diabetes treatment to achieve better glycemic control in patients with type 2 diabetes 
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(Danne et al., 2017). CGM system measures the glucose levels in the interstitial fluid of 
subcutaneous adipose tissue. The physiological basis of this instrument is that glucose 
molecules can diffuse freely through the capillary endothelium into the interstitium so 
that a dynamic equilibrium can be reached. Previous studies showed that interstitial 
glucose is highly correlated with venous glucose and capillary glucose (Thennadil et al., 
2001). An important advantage of CGM is its ability to detect asymptomatic 
hypoglycemia. A study reported that three days of CGM wearing detected asymptomatic 
hypoglycemia in 46.6% of patients with type 2 diabetes, and the frequency of 
hypoglycemic events was similar between daytime and nighttime (Chico, Vidal-Ríos, 
Subirà, & Novials, 2003). 
CGM provides uninterrupted measures of interstitial fluid glucose levels 
throughout the day using sensors that are placed subcutaneously. The newest generation 
of CGM product does not require manual calibration based on the capillary glucose levels 
since it is already calibrated in the factories. Whether the use of CGM can improve 
glucose control in patients with type 2 diabetes remains unknown. However, CGM has 
been exceedingly useful in the field of exercise physiology because it captures the 
dynamic glucose changes during and after exercise. It is also an excellent tool to examine 
the duration of the glucose-lowering effect of exercise.  
Assessing Insulin Sensitivity 
Hyperinsulinemic-euglycemic clamp test: The clamp procedure has been 
considered as the gold standard of insulin sensitivity measurement. However, its 
application is greatly limited by the high cost and complicated techniques. The procedure 
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is usually performed in a hospital setting. A stable high level of plasma insulin 
concentration is achieved through venous insulin infusion, while glucose infuses also 
performed to maintain physiological plasma glucose levels. When the steady-state is 
achieved, the glucose uptake matches the glucose infusion rate. With the known insulin 
levels and glucose infusion rate, insulin sensitivity can be directly quantified (DeFronzo, 
Tobin, & Andres, 1979).  
Insulin suppression test (IST): IST is another way to measure insulin sensitivity 
directly and is well correlated with the clamp values in both healthy subjects and type 2 
diabetic subjects (Greenfield, Doberne, Kraemer, Tobey, & Reaven, 1981; Muniyappa, 
Lee, Chen, & Quon, 2008).  
Frequent sampled intravenous glucose tolerance test (FSIGTT): After an 
overnight fast, glucose is administered intravenously in the first 2 minutes, and insulin is 
administered from 20 minutes to 25 minutes. A total of 31 blood samples will be 
collected for plasma glucose and serum insulin during the 3 hours. The FSIGVTT 
requires less labor and is feasible for epidemiological studies. It has been validated for 
the estimation of insulin sensitivity and beta-cell function (Pacini & Bergman, 1986).   
Homeostasis model assessment (HOMA) and quantitative insulin sensitivity 
check index (QUICKI): Both HOMA and QUICKI are used to estimate insulin sensitivity 
at fasting steady-state (Matthews et al., 1985). HOMA is primarily used in large-scale 
epidemiological studies where the glucose clamp tests are not feasible. QUICK has better 
reliability as compared with HOMA and can be used in intervention studies where insulin 
sensitivity is not the primary outcome (Muniyappa et al., 2008). 
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Models based on the oral glucose tolerance test (OGTT): Many methods (e.g., 
Matsuda index) to estimate insulin sensitivity have been available using the glucose and 
insulin levels during the OGTT (Matsuda & DeFronzo, 1999). Those methods provide 
the estimated insulin sensitivity that is well correlated with the glucose clamp test. Using 
the insulin and glucose levels during an OGTT is a simple way to estimate insulin 
sensitivity, and its outcomes have been well correlated (r=0.73) with the 
hyperinsulinemic-euglycemic clamp procedure (Matsuda & DeFronzo, 1999). 
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Effect of Exercise on Postprandial Glucose in Type 2 Diabetes 
Limitations of Pharmacological Treatment 
Although metformin is considered as the first-line medication for the treatment of 
type 2 diabetes, it is not the optimal option for every patient. First, drug intolerance (i.e., 
gastrointestinal symptoms) occurs in 20-30% of patients that are treated by metformin, 
and severe intolerance that results in medication discontinuation occurs in 5% of patients 
(Diabetes Prevention Program Research Group, 2002; Kirpichnikov, McFarlane, & 
Sowers, 2002). Secondly, some patients are poor responders to metformin (Florez, 2017). 
Due to unsatisfactory glycemic control, dosage escalation is very common in metformin 
monotherapy (Garber, Duncan, Goodman, Mills, & Rohlf, 1997; Turner, Cull, Frighi, & 
Holman, 1999). Treatment failure (a fasting plasma glucose level >180 mg/dL [10 
mmol/L]) happens in up to 21% of patients receiving metformin monotherapy at five 
years (Kahn et al., 2006). Lastly, there is insufficient evidence to conclude that 
metformin reduces cardiovascular diseases in patients with type 2 diabetes (Griffin, 
Leaver & Irving, 2017). Insulin injection and insulin secretagogues intake also have 
several side-effects. The most common side effect is hypoglycemia, which can cause 
palpitations, loss of consciousness, and even death. Another common side effect of 
insulin treatment is insulin-associated weight gain, which can worsen the cardiovascular 
risks in diabetic patients (Russell-Jones & Khan, 2007). Exploring novel methods for 
improving glycemic control is needed.  
It has been well established that post-meal physical activity can attenuate the 
postprandial glucose excursions. Høstmark et al. (2006) showed that 30 minutes of light 
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cycling after the consumption of carbohydrates significantly decreased the rise in blood 
glucose, as compared to the sitting control condition. Larsen et al. (1997) demonstrated 
that 45 minutes of cycling at 53% of VO2max elicited a significant decrease in glucose 
AUC after breakfast.  
Timing of Exercise 
Exercise should be performed at the postprandial status to maximize its glucose-
lowering effect. Colberg and her associates (2009) investigated the influence of exercise 
timing on postprandial glucose in 12 older patients (age, 61.4±2.7 years) with type 2 
diabetes. The authors concluded that 20 minutes of moderate-intensity aerobic exercise 
that was performed 15 to 20 minutes after a standardized dinner induced significantly 
lower glucose levels at 90 minutes, as compared with a similar amount of exercise that 
was performed immediately before the dinner. Consistent findings have been reported in 
diabetic patients who were taking metformin. A study that examined the effect of post-
meal exercise showed a significant decrease in postprandial glucose AUC (Erickson et 
al., 2017a), while other studies that examined the effect of pre-meal exercise failed to 
observe a significant decrease in postprandial glucose levels (Boulé et al., 2011; Myette-
Côté, Terada, & Boulé, 2016). 
Duration of the Glucose-Lowering Effect 
Although a single bout of post-meal exercise can significantly lower postprandial 
glucose, the glucose-lowering effect does not last to the next meal. In the study by Larsen 
et al. (Larsen et al., 1997), nine sedentary patients with diabetes underwent the two 
conditions in random order: 1) 45 minutes of cycling at 53% of VO2max performed 45 
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minutes after breakfast; 2) resting control. At 4 hours after the breakfast, participants in 
both conditions consumed a standardized lunch. The study outcomes showed that the 
post-breakfast glucose AUC was lower in the exercise condition compared to the resting 
condition. However, post-lunch glucose AUC did not differ between the two conditions. 
The authors also showed that the glucose appearance rate and disappearance rate 
following the consumption of lunch were not different between the exercise and resting 
conditions, while an increase in glucose disappearance rate was observed during the 
exercise treatment, suggesting that the muscle contraction-induced glucose uptake did not 
persist after the cessation of exercise activities. A crossover study in patients with type 2 
diabetes examined the effects of 45 minutes of moderate-intensity, post-breakfast 
exercise on postprandial glucose levels over the 24 hours after the exercise bout (Van 
Dijk et al., 2013). Their results revealed that glucose iAUC was reduced by 92 
mmol/L·3.5h after breakfast, 39 mmol/L·3.5h after lunch, and 34 mmol/L·3.5h after 
dinner. Although the glucose-lowering effect persisted after-dinner consumption, the 
magnitude of the glucose-lowering effect after dinner was 63% lower than that after 
breakfast, suggesting that the impact of exercise on glucose levels declines rapidly after 
the cessation of exercise.  Another study revealed that 40 minutes of slow, light-intensity 
walking only decreased the glucose levels during the exercise bout (Nygaard, Tomten, & 
Høstmark, 2009). The effect of exercise completely discontinued at 120 minutes. 
Collectively, the duration of the glucose-lowering effect of acute exercise is short. The 
strongest effect occurs during the exercise bout. 
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Intensity of Exercise 
It is important to choose an appropriate exercise intensity for lowering glucose in 
diabetic patients. A study examined the acute effect on low (35% of maximal workload) 
and high-intensity exercise (70% of maximal workload) that were matched with energy 
expenditure in 9 participants with diabetes (Manders et al., 2009). The CGM data showed 
that lower intensity exercise-induced lower 24-hour glucose than did the high-intensity 
exercise. Mean glucose at postprandial status was not significantly different between 
groups. However, moderate-intensity exercise seemed more effective than light intensity 
exercise when the duration, not energy expenditure, was matched. The study by Van Dijk 
et al. (2013), showed that 45 minutes of moderate-intensity exercise resulted in lower 24-
hour glucose and postprandial glucose, as compared with three bouts of 15-minute light-
intensity exercise. 
Nevertheless, the influence of exercise intensity on glucose changes varies in 
different populations. Shambrook and colleagues (2017) investigated the effect of 
exercise intensity on postprandial glucose responses in 10 healthy, insufficiently active 
males. Participants underwent 3 exercise conditions and a sitting control condition in 
random order. The 3 exercise treatments were 30-minute cycling at 3 different intensities, 
including 35%, 50%, and 80% of VO2 Reserve. The different conditions were separated 
by a one-week wash-out period, and each treatment of the exercise was performed 30 
minutes after the consumption of breakfast. The postprandial glucose was assessed using 
the CMG system. Their outcomes showed that all exercise treatments significantly 
lowered postprandial glucose compared to the sitting control, whereas no glucose 
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differences were observed across different exercise intensity conditions. The chronic 
effects of exercise training at different intensities have also been reported. A study in 
sedentary, overweight/obese participants revealed that, at a given exercise volume (12 
miles per week), moderate-intensity exercise (40% of VO2 Peak) elicited greater 
improvement in insulin sensitivity than did high-intensity training (85% of VO2 Peak) 
(Houmard et al., 2004). On the other hand, at the given exercise intensity (85%), high 
volume training (20 miles per week) is more effective in enhancing insulin sensitivity, as 
compared with low volume training.  
 
Duration of Exercise 
The duration of the post-meal exercise is inversely associated with postprandial 
glucose levels. Using a crossover design, Lunde, and colleagues (2012) compared the 
effect of 20 minutes of post-meal walking with 40 minutes of post-meal walking in 11 
participants without diabetes. They showed that 20 minutes of walking decreased the 
postprandial glucose AUC by 30.6% compared to sitting condition, while 40 minutes of 
walking induced a 39% decrease in glucose AUC. Also, the peak glucose was 
significantly lower in the 40-minute walk group than in the 20-minute walk group. To 
date, most studies showed that 30 to 60 minutes of post-meal exercise is sufficient to 
blunt postprandial hyperglycemia (Erickson et al., 2017a; Erickson et al., 2017b; Larsen 
et al., 1997; Van Dijk et al., 2012; Van Dijk et al., 2013). 
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Resistance Exercise 
Resistance exercise has also been shown as effective in reducing postprandial 
glucose. Heden and colleagues (2017) investigated the acute effect of a single session of 
resistance exercise on postprandial glucose in 11 patients with type 2 diabetes. The 45 
minutes of resistance exercise involved all major muscle groups of upper and lower 
extremities and abdominal at the intensity of 50-100% of 10 repetition maximum (10-
RM). The mean glucose during exercise was 23% lower in the intervention group than in 
the sitting control group (P<0.01). Interestingly, resistance exercise performed in 
intermittent patterns may also benefit glucose management. A more recent study revealed 
that multiple short bouts (a 3-min bout every 30 minutes) of resistance exercise decreased 
glucose AUC by 39% compared to sitting control (Dempsey et al., 2016). Additionally, 
short-term resistance training has been shown as effective in improving glycemic control 
in patients with diabetes. Castaneda and colleagues (2002) revealed that 16 weeks of 
resistance training (three sessions/week, 45 min/session, 60-80% of 1-RM) significantly 
decreased HbA1c (8.7% pre-training vs. 7.6% post-training) in older adults with diabetes. 
Exercise Pattern: Single Bout vs. Multiple Bouts 
In the study by DiPietro and colleagues (2013), 10 sedentary individuals 
underwent 3 experiment conditions that were 4 weeks apart: 1) a single bout of 45-
minute, continuous walking at the intensity of 3 metabolic equivalents (METs) performed 
at 10:30 am; 2) 45-minute of walking that was performed at 4:30; 3) three bouts of 15-
minute walking at the same intensity that were performed 30 minutes after breakfast 
(8:00 am), lunch (12:00 pm), and dinner (6:00 pm), respectively. The day before each 
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exercise experiment served as a control condition. Their results showed that the 45-
minute morning exercise and the three bouts of 15-minute exercise were equally effective 
in reducing 24-hour average glucose, while the 45-minute, afternoon exercise treatment 
does not affect 24-hour average glucose. There has been emerging evidence regarding the 
metabolic effects of short, frequent exercise (e.g., 5 min of exercise hourly). Holmstrup 
and colleagues (2014) revealed that performing 5 minutes of exercise every hour for 12 
hours produced a superior effect on glucose, as compared to time- and intensity-matched, 
single-bout exercise among obese persons. Similarly, Peddie et al. (2013) also observed a 
similar trend in healthy, normal-weight persons. In their study, 100 seconds of walking 
every 30 minutes were more effective in decreasing postprandial glucose levels compared 
to 30 minutes of continuous exercise at the same intensity.   
The Interaction between Exercise and Medication 
Several acute and short-term studies have investigated the interaction between 
exercise and metformin. In the study by Boulé et al. (2013), 251 patients with type 2 
diabetes were randomly assigned to aerobic exercise, resistant exercise, or combined 
exercise groups. There were 143 metformin users and 82 non-metformin users. At the 
end of the 22 weeks of the exercise training intervention, the overall HbA1c reductions 
were not significantly different between metformin users and non-metformin users. In 
another study, Boulé et al. (2011) also examined the acute effect of exercise on glucose in 
metformin users and non-metformin users. The participant arrived at the lab and ate a 
standardized meal at 8 am. All participants performed an exercise session that included 
both resistant exercise and aerobic exercise between 10:45 to 11:40. Postprandial glucose 
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levels were measured after lunch. The study outcomes showed that, among metformin 
users, postprandial glucose tended to be higher in exercise condition than in the control 
condition, while among non-metformin users, postprandial glucose was similar between 
the two conditions. Other investigators have also shown an interaction between 
metformin and exercise.  Malin and colleagues (Malin, Gerber, Chipkin, & Braun, 2012) 
conducted a randomized controlled trial to examine the effect on insulin sensitivity of a 
12-week exercise training program with or without concurrent metformin intake in 32 
participants with prediabetes. The euglycemic-hyperinsulinemic clamp tests showed that 
both exercise and metformin were effective in improving insulin sensitivity compared to 
the control group, but the increase in insulin sensitivity was 25% greater in the exercise 
alone group than in the exercise and metformin combined group, which suggested that 
metformin intake potentially undermined the beneficial effect of exercise on insulin 
sensitivity. Additionally, recent studies provided novel insight into this problem and 
identified the importance of exercise timing to achieve the optimal effect on glucose 
metabolism. Erickson and colleagues (Erickson et al., 2017a; Erickson et al.,  2017b) 
conducted two randomized controlled trials and revealed that performing an exercise at 
the postprandial period reduced blood glucose levels in both patients on metformin 
monotherapy and patients receiving multiple oral medications. 
Exercise in Insulin-treated Type 2 Diabetics 
The potential risk of hypoglycemia during and after exercise in insulin-treated 
patients should be noted. Pre-exercise glucose monitoring is recommended for patients 
receiving insulin treatment, especially those receiving intensive insulin regimens (i.e., 
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multiple daily injections and insulin pump therapy). If pre-exercise blood glucose is 
lower than 100 mg/dL (5.6 mmol/L), 15 grams of carbohydrates should be consumed 
before exercise. Prolonged, vigorous exercise should be avoided in patients with 
proliferative or severe retinopathy. Exercise should be avoided if blood glucose is higher 
than 250 gm/dL (American College of Sports medicine, 2016). 
Monitoring Exercise Intensity 
The percentage of heart rate max (%HRmax) or percentage of heart rate reserve 
(%HRR) are both commonly used for assessing exercise intensity. Both methods are 
based on the linear relationship between heart rate and oxygen consumption during 
exercise. Therefore, attention should be given to conditions that can influence the heart 
rate or heart rate response to exercise. Diabetic cardiovascular autonomic neuropathy 
(CAN) is a common complication of diabetes. The CAN can increase resting heart rate 
and decrease HRmax. Colberg and colleagues (2003) compared the heart rate responses 
to exercise in middle-age to older patients with and without the CAN. Their results 
supported the existence of a linear relationship between %HRR and oxygen consumption 
(r=0.98), and a linear relationship between the rate of perceived exertion (RPE) and VO2 
Reserve (r=0.94). However, it is important to note that resting HR and HRmax must be 
accurately determined via exercise testing rather than estimated using age-predicted 
HRmax. Another factor is the usage of beta-blocker since heart disease is a common co-
morbidity in patients with diabetes. Beta-blocker can lead to inaccurate assessment of 
exercise intensity when using heart rate-based measurement because both resting HR and 
HRmax are suppressed by beta-blocker. Wonish and colleagues (2003) conducted a 
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randomized crossover design study to compare the heart rate responses to aerobic 
exercise with and without concurrent beta-blocker intake in 10 healthy males. The results 
showed that, at any given workload, the %HRmax and %HHR are consistently lower in 
those who were taking beta-blockers than in those who were taking a placebo, while the 
RPE outcomes were similar between the two groups, suggesting that RPE can be used as 
a substitute in beta-blocker takers to assess exercise intensity accurately.  
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Mixed Meal Test and Confounding Variables 
Mixed Meal Test 
Both mixed meal tests and oral glucose tolerance tests have been commonly used 
in the determination of postprandial glucose responses to diet and exercise interventions 
in patients with type 2 diabetes. Wolever et al. (1998) compared the 75-g oral glucose test 
and the 87-g mixed meal test (containing 8.9 simple sugar and 41.1 starch) in 10 patients 
with type 2 diabetes. The outcomes showed that the 2-h glucose levels obtained from the 
two tests were highly correlated (r=0.97), and the glucose variances between subjects (the 
ratio of the standard deviation to the mean) were also comparable between the two tests. 
Mixed meal tests and oral glucose tolerance tests produced similar glucose excursion 
patterns, but the magnitude of glucose increase was lower in the mixed meal tests. The 
peak glucose was approximately 70 mg/dL (3.9 mmol/L) lower in the mixed meal test 
than in the oral glucose test. These outcomes suggested that the mixed meal test was a 
valid measurement tool for studies using postprandial glucose as the main outcomes. 
Factors that Influence the Postprandial Glucose 
Physical Activity  
Several studies reported that the improvement in insulin sensitivity after a single 
session of moderate to vigorous-intensity exercise might persist for a few hours to up to 
16 hours (Devlin, Hirshman, Horton, & Horton, 1987; Wojtaszewski et al., 2000). 
Mikines et al. (1988) demonstrated that a single bout of 60-minute cycling exercise 
enhanced insulin sensitivity for 48 h in untrained individuals. Similarly, an increase in 
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insulin sensitivity persisted for up to 24 hours after a single session of resistance exercise 
(Koopman et al., 2005). Therefore, it is necessary to refrain from moderate to vigorous-
intensity exercise and resistance exercise 48 hours before glucose tolerance or insulin 
sensitivity test.  
Food Intake 
A study showed that consuming a meal with a high content of saturated fat was 
associated with decreased insulin sensitivity during the postprandial period, and the effect 
persisted to the next meal (Robertson, Jackson, Fielding, Williams, & Frayn, 2002). 
Another study demonstrated that consuming a high-fat diet for one-day impaired insulin 
sensitivity in the following day and this impairment did not completely return to the 
baseline level after one day of normal diet (Koska et al., 2016). 
Caffeine 
A study showed that concurrent caffeine intake when consuming glucose drinks 
increased both postprandial glucose and insulin levels in healthy individuals (Johnston, 
Clifford, & Morgan, 2003). 
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Special Considerations of Exercise Testing and Prescription 
Glycemic Control in the Older Adults 
The glycemic target in older adults with diabetes is usually based on a 
comprehensive review of the benefits of tighter glycemic control, the potential risk of 
hypoglycemia, and treatment burden. In general, a more relaxed HbA1c target (e.g., 7.5, 
8.0, or 8.5) is recommended in the frail older adults (e.g., those with functional 
impairment). An individualized treatment goal rather than a standardized glycemic target 
is usually used in older adults. 
Hypoglycemia in Older Adults with Type 2 Diabetes 
Hypoglycemia is defined as a glucose level of ≤ 70 mg/dL (3.9 mmol/L), and 
clinically significant hypoglycemia is defined as a glucose level of ≤ 54 mg/dL (3 
mmol/L) (ADA, 2017). It has been estimated that the frequency of mild hypoglycemia is 
approximately 0.1 to 0.3 events/patient-days in insulin-treated type 1 diabetics (Fanelli et 
al., 2002). The risk of hypoglycemia is associated with the duration of insulin treatment 
(Hepburn, MacLeod, Pell, Scougal, & Frier, 1993; UK Prospective Diabetes Study 
[UKPDS] Group, 1998). In patients with long-standing type 2 diabetes, the risk of 
hypoglycemia is similar to that in patients with type 1 diabetes (Hepburn et al., 1993). 
High-quality data on the frequency of mild hypoglycemia lacks because patients are often 
unaware of mild hypoglycemia, and the capillary glucose measures are usually 
ineffective in capturing all hypoglycemic events. Severe hypoglycemia is a life-
threatening condition that can lead to acute cardiovascular events, such as stroke and 
myocardial infarction. Older adults have a reduced awareness of hypoglycemia, which 
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makes hypoglycemia a particular concern in the older population (Bremer, Jauch-Chara, 
Hallschmid, Schmid, & Schultes, 2009; Zammitt & Frier, 2005).  The risk of 
hypoglycemia is higher in persons treated with endogenous insulin or insulin 
secretagogues (e.g., sulfonylureas). A study reported that the incidence of severe 
hypoglycemia (glucose level ≤ 50 mg/dL [2.8 mmol/L] or requires emergent medical 
intervention) is about two events per 100 person-years (Shorr, Ray, Daugherty, & Griffin, 
1997). Previous exercise training studies in older patients did not report an increased risk 
of hypoglycemia in the exercise training group compared to the control group (Ceriello et 
al., 2002; Dunstan et al., 2002). However, none of these studies applied continuous 
glucose monitoring, therefore potential hypoglycemic events may be undetected.     
Exercise Testing and Prescription in Older Adults 
Older patients with type 2 diabetes are heterogeneous due to various co-
morbidities and diabetic complications. The American College of Sports Medicine 
(ACSM) guidelines recommend that older adults can initiate light-intensity exercise 
without exercise testing, unless a test is indicated by certain medical conditions, such as 
symptomatic CVD or uncontrolled diabetes. Existing evidence does not suggest that 
exercise is associated with increased mortality in the older population. The risk of cardiac 
events (e.g., myocardial infarction) is minimal during moderate-intensity physical 
exertion (Mittleman et al., 1993). Additionally, only a small proportion of older adults 
can satisfactorily complete an exercise stress test (Hollenberg, Ngo, Turner, & Tager, 
1998). Also, the exercise ECG test in older adults has a higher false-positive rate because 
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older adults are more likely to have electrocardiographic abnormalities that are associated 
with aging instead of a clinically important diagnosis (Furberg et al., 1992). 
Exercise in Patients with PAD 
Although the exercise ability is limited in patients with PAD, a large body of 
literature has demonstrated the benefit of exercise in patients with PAD (Gerhard-
Herman, 2017). Supervised, weight-bearing exercise has been shown as the most 
effective compared to unsupervised exercises and non-weight-bearing exercises (Norgren 
et al., 2007). A randomized controlled trial revealed that six months of exercise training 
in patients with PAD induced superior improvements in walking ability and PAD 
symptoms compared to stent revascularization treatment (Murphy, 2012). 
Exercise in Patients with PND 
Exercise is not contraindicated in persons with diabetic peripheral neuropathy. 
Due to the risk of foot ulcers, non-weight-bearing exercises are recommended in this 
population. Daily examination of feet should be performed to inspect skin changes and 
ulcerations (American College of Sports Medicine [ACSM], 2016). The beneficial effects 
of exercise on physical function and PND symptoms have been well documented in the 
literature (Dixit, Maiya, & Shastry, 2014; Kluding, 2012; Richardson, Sandman, & Vela, 
2001). 
Exercise in Patients with Arthritis 
Mild discomfort can occur during or after exercise, which usually does not 
indicate joint injury or damage. Exercise modalities that produce low joint loadings are 
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preferred. (ACSM, 2016) Both isokinetic vs. isometric exercise modalities showed 
promise in alleviating joint pain and improving muscle strength in patients with arthritis 
(Anwer, & Alghadir, 2014; Rosa, 2012). 
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Evaluation and Classification of Physical Function 
Guralnik and his associates (1994) validated the application of both self-reported 
disability and simple, functional tests in more than 5,000 community-dwelling older 
individuals aged ≥ 65 years. The functional tests included an 8-feet walking test, a 5-time 
sit-to-stand test, and a standing balance test (i.e., side-by-side standing, semi-tandem 
standing, and tandem standing). The three tests were summarized in a 12-score scale, 
with 0 indicating the worst performance and 12 indicating the best performance. The self-
reported disability questions identified two levels of disability. ADL disability was 
considered as present if the participant reported difficulties in using the toilet, transferring 
between chairs and bed, bathing, or walking across a small room. On the other hand, 
mobility disability was confirmed if the participant reported difficulties in walking 0.5 
miles or climbing stairs to the second floor. The study showed that the outcomes from 
self-reported disabilities and the 12-points scale were highly associated. The study also 
showed that both self-reported disabilities and functional tests were significant predictors 
of mortality institutionalization.  
Three main types of functional tests are most commonly used in the assessment of 
lower-extremity function. They are standing balance test, gait speed test, and sit-to-stand 
test. 
Standing Balance Test 
The Berg Balance Test is a 14-item instrument that involves 14 different tasks 
(e.g., standing with eyes closed and standing on one foot, etc.). This test is associated 
with fall risks in the elderly (Bogle Thorbahn & Newton, 1996). The limitation of the 
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Berg Balance test is that it requires too many tools. Therefore, it may not be easily 
applied in community settings outside the lab. Another standing balance test consists of 
three tasks, which are a side-by-side stand, tandem stand, and semi-tandem stand. The 
score of this test ranges from 0 to 4, with 0 meaning the weakest performance and 4 
meaning the best performance. This test does not require specific tools, and each task 
lasts ≤ 10 seconds. This test can be easily applied in various settings. A study by Guralnik 
et al. (1994) showed that the older persons who performed poorly on this standing test 
had a higher risk of both ADL-related and mobility-related disabilities.  
Gait Speed Test 
Gait speed, or walking speed, has been considered as a meaningful indicator of 
physical function and the well-being of older adults. The validity and reliability of gait 
speed tests have been tested in various populations (Afilalo et al., 2010; Green, Forster, & 
Young, 2002; Podsiadlo & Richardson, 1991). A gait speed below 1m/sec has been 
shown as an indicator of an increased risk of subsequent disability (Guralnik et al., 2000). 
Also, a cohort study of 131 patients (mean age: 75.8 years) showed that gait speed test 
was a significant predictor of mortality and major morbidities (e.g., stroke, renal failure, 
etc.) in the elderly patients (Afilalo et al., 2010). A repeated measure study examined the 
reliability of three identical gait speed tests with one-week intervals between tests. Their 
results revealed high intraclass correlations (0.95–0.99) for within-test reliability (Green, 
Forster, & Young, 2002).  
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5-Repetition Sit-to-stand Test  
The 5-repetition sit-to-stand test is a reliable, practical tool to measure the muscle 
strength of lower extremities. During the test, participants stand up fully and sit down on 
a 16-inch chair as quickly as possible for five times, while keeping their arms folded 
across the chest. The participants have two trials, and the time to complete each trial is 
recorded using a stopwatch. A meta-analysis summarized the reference values of this test 
for people ≥ 60 years and concluded that the performance was considered below average 
if the test takes ≥ 11.4 seconds for persons aged 60 to 69 years, 12.6 seconds for persons 
aged 70 to 79 years, or 14.8 for persons aged 80 to 89 years (Bohannon, 2006). 
Voluntary Cycling 
The mechanisms of the glucose-lowering effect of voluntary cycling exercise fall 
within the scope of general exercises, which involve repeated muscle contractions. 
Previous studies have demonstrated that the transport of glucose through the cell 
membranes is the rate-limiting step of peripheral glucose utilization (Kubo & Foley, 
1986). In human skeletal muscle cells and adipocytes, GLUT 4 is the primary glucose 
transporter isoform (Shepherd & Kahn, 1999). It has been revealed that the GLUT4 
content and gene expression in the muscle tissues of patients with type 2 diabetes are 
unaffected compared to healthy individuals (Handberg, Vaag, Damsbo, Beck-Nielsen, & 
Vinten, 1990). However, the translocation of GLUT4 from the intracellular vesicles, 
where GLUT4 is stored at resting state, to the cell membrane in response to insulin is 
severely impaired, causing peripheral insulin resistance (Dohm et al., 1988). On the other 
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hand, the translocation of GLUT4 in response to exercise remains normal in patients with 
type 2 diabetes (Kennedy et al., 1999). Kennedy et al. (1999) has shown that a single bout 
of cycling exercise could induce the translocation of GLUT4 in patients with type 2 
diabetes and caused a significant increase in GLUT4 at the muscle cell membrane. This 
GLUT4 translocation process involves several intracellular signaling pathways, including 
the Ca2+/calmodulin-dependent protein kinase II (CaMKII) pathway and the adenosine 
monophosphate-activated protein kinase (AMPK) pathway (Richter & Hargreaves, 
2013). 
In addition to the primary action of GLUT4 translocation, exercise can also 
promote peripheral glucose uptake via several other mechanisms. The increased 
microvascular blood flow and the increased surface area between the capillary and 
myocytes also contribute to the enhanced glucose uptake during exercise (Sjøberg, 
Rattigan, Hiscock, Richter, & Kiens, 2011; Vincent et al., 2006). Vincent and her 
associates (2006) studied the microvascular blood volume and blood flow in working 
muscles among 18 healthy individuals. They observed an increase in blood flow 
immediately after the muscle contractions. Even low-intensity exercise increased 
microvascular blood volume by three times as compared with resting status. Also, Christ-
Roberts et al. (2003) proposed a synergistic effect of exercise and insulin by comparing 
peripheral glucose uptake during insulin infusion with and without concurrent exercise 
(Kanai et al., 1993). 
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Motor-Assisted Cycling 
In 1949, Saunders reported an increase in energy expenditure during passive 
movement in five medical students. It was also noticed that a positive association existed 
between energy expenditure and cycling cadence. The author speculated that the 
increased muscle tones and muscle activities to maintain balance were responsible for the 
metabolic cost of passive cycling. The muscle activities during passive cycling were 
confirmed in a later study. Researchers measured the leg muscle activities during resting 
and motor-assisted cycling using electromyography and showed that the muscle activity 
increased upon the start of motor-assisted cycling and returned to resting level after the 
cessation of the passive movement, indicating that performing motor-assisted cycling 
activated leg muscle contractions (Bell et al., 2003). This conclusion was further 
supported by the increase in oxygen consumption observed during the motor-assisted 
cycling exercise, showing that motor-assisted cycling increased energy expenditure (Bell 
et al., 2003). Peterman and colleagues (Peterman, 2012) examined the factors that 
influenced the energy expenditure during motor-assisted cycling. The energy expenditure 
was 1.28 kcal/min at sitting status, 1.49 kcal/min during unilateral motor-assisted cycling 
at 60 RPM, 1.85 kcal/min during unilateral motor-assisted cycling at 90 RPM, and 2.51 
kcal/min during bilateral motor-assisted cycling at 90 RPM. These results suggested that 
a higher cycling cadence was associated with greater energy expenditure. Notably, the 
changes in energy expenditure from sitting to exercise was twofold during bilateral 
cycling as that during unilateral cycling, suggesting that the bilateral motor-assisted 
cycling activated twice as muscle mass as did the unilateral cycling. Another finding of 
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that study was that the increased energy expenditure sustained throughout the 30 minutes 
of continuous motor-assisted cycling, revealing that human bodies did not habituate to 
the passive movement or learn to minimize the muscle activation during passive 
movement. This finding was consistent with the previous study that the energy 
expenditure during motor-assisted cycling did not decline over repeated trials 
(Krzemiński et al., 2000). Another study among intensive care unit patients showed that 
36 sessions of motor-assisted cycling at a slow speed (20 revolutions per minute, 20 
minutes per session, 5 days per week) elicited greater increase in muscle strength 
(measured by Medical Research Council Scale), as compared with conventional physical 
therapy, suggesting that motor-assisted cycling was effective in restoring impaired 
muscle strength in immobile patients (Machado et al., 2017). Overall, the literature 
suggested that motor-assisted cycling was a beneficial exercise modality in persons with 
limited exercise ability.  
FES Cycling 
The FES cycling protocols based on motor-driven bikes have been studied in 
patients with SCI (Ambrosini, Ferrante, Pedrocchi, Ferrigno, & Molteni, 2011). The 
participants performed motor-assisted cycling at a fixed cadence (e.g., 20 rpm), and 
electrodes were placed on quadriceps, hamstrings, gluteus, and tibialis anterior. A 
multiple-channel, programmed stimulator delivered electrical stimulations that were 
synchronized to the motor-assisted cycling movement (Ambrosini et al., 2011). FES 
cycling can also be achieved based on the volitional cycling movement. A computerized 
program was used to detect the volitional cycling movement, allowing coordinated 
electrical stimulation to be generated at appropriate crank angles to facilitate the cycling 
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movements and increase the total torque of the contracting muscles (Szecsi, Krewer, 
Müller, & Straube, 2008). This feature of FES cycling makes it also beneficial for 
persons who do not have SCI (Hunt, Fang, Saengsuwan, Grob, & Laubacher, 2012). 
Accumulating evidence supports a beneficial effect of FES cycling on glucose 
metabolism. It has been shown that ten weeks of FES cycling significantly improved 
glucose tolerance (i.e., attenuated postprandial glucose and insulin levels) and body 
composition in persons with SCI (Griffin et al., 2009). Similarily, Jeon et al. (2002) 
showed that eight weeks of FES cycling increased peripheral glucose uptake, as 
measured by the hyperglycemic clamp test. Hunt et al. (2006) demonstrated that the 
energy expenditure during FES cycling at 50 rpm was approximately 2-2.5 times as much 
as the resting energy expenditure in an individual with paraplegia. This outcome was 
consistent with findings from previous research. In the study by Harness and Astorino 
(Harness & Astorino, 2011), the acute energy cost of FES cycling at 45 rpm was 
measured using indirect calorimetry in seven patients with SCI. The study showed that 
the intensity of FES cycling was 2.5 METs. Notably, one MET in SCI patients equaled 
2.7 ml/kg/min in SCI patients due to the loss of muscle mass and long-term inactivity 
(Bauman & Spungen, 2000; Collins et al., 2010). An important advantage of FES cycling 
is that a fast cadence is not required to elicit metabolic changes, making it more tolerable 
for severely deconditioned persons. A study showed that FES cycling at 15, 30, and 50 
rpm induced similar changes in oxygen consumption and respiratory exchange ratio, 
revealing that the cycling cadence was not a primary factor for determining the metabolic 
responses to FES cycling (Fornusek et al., 2008). Additionally, FES cycling has been 
42 
 
shown to improve muscle strength (Donaldson, Perkins, Fitzwater, Wood, & Middleton, 
2000) and gait speed (Ambrosini et al., 2011), suggesting that FES cycling is a promising 
rehabilitation exercise for individuals with disabilities. 
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Summary 
As endorsed by the ACSM and the ADA, the benefits of exercise on glycemic 
control were well documented. The literature of review indicated that 30 minutes of 
exercise performed after the consumption of carbohydrates was sufficient to induce an 
acute reduction in glucose levels among patients with type 2 diabetes. However, the 
traditional exercise modalities (e.g., treadmill walking and upright cycling) tested in the 
previous studies may not be appropriate for older patients with ADL disabilities. 
Therefore, we presented evidence regarding the beneficial effects of alternative exercise 
modalities (i.e., motor-assisted cycling and FES cycling) on glucose management in 
patients with spinal cord injuries and stroke. It has not been tested whether these exercise 
modalities will elicit similar effects in the deconditioned population who suffers from 
type 2 diabetes and ADL disabilities. There is a need to test the effects of motor-assisted 
cycling and FES cycling on blood glucose levels in diabetic patients with ADL 
disabilities.   
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CHAPTER 3 
RESEARCH DESIGN AND METHODS 
Overview of Research Design 
The study was approved by the institutional review board at Arizona State University 
(Appendix A). We conducted a 3×3 crossover study design (3 sequences, 3 periods) to test 
the acute effects of motor-assisted cycling, FES cycling, and sitting control on postprandial 
glucose among type 2 diabetic patients with ADL disabilities. After the screening and 
familiarization visits, the study participants (N = 9) were randomly assigned (1:1:1 ratio) to 
one of the three treatment sequences: ABC, BCA, and CAB (A indicates motor-assisted 
cycling; B indicates FES cycling; C indicates sitting control) (Figure 1).  
 
 
Figure 1. Flow Diagram of the Study  
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The randomization procedure was conducted using an online program 
(https://www.sealedenvelope.com/ simple-randomiser/v1/lists). Glucose was assessed 
using the CGM system.  
 
Eligibility Criteria, Recruitment, and Sample Size 
This study recruited older participants with type 2 diabetes and ADL disabilities. 
Participants were recruited from assisted-living centers in Phoenix Metro. Site permission 
letters were obtained by the assisted-living centers' officials to authorize the researchers to 
recruit participants, implement a treatment, and perform data collection during the period of 
2/16/2018 to 2/16/2020. The community staff nurses assisted in the recruitment process. 
Recruitment fliers (Appendix B) were displayed in the main hall and the mailbox. We were 
also able to advertise this study during their community-wide events. The inclusion and 
exclusion criteria were summarized as follows.  
Inclusion Criteria 
• Age above 60 years;  
• Physician-diagnosed type 2 diabetes; 
• At least one ADL disability (self-reported data using a validated questionnaire) 
(Katz, Downs, Cash, & Grotz, 1970); 
Exclusion Criteria  
• Fasting glucose ≥ 250 mg/dL (13.9 mmol/L) [A fasting glucose of 250 mg/dL 
(13.9 mmol/L) or higher is associated with risk of hyperglycemia crisis (Kitabchi, 
Umpierrez, Miles, & Fisher, 2009)]; 
• Symptomatic hypoglycemic events in the past three months; [Exercise may 
increase the risk of hypoglycemia (Cryer, Davis, & Shamoon, 2003)];  
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• Insulin injection or infusion; 
• Systolic blood pressure ≥ 160 mmHg  
OR  
Diastolic blood pressure ≥ 100 mmHg [systolic blood pressure > 200 mm or 
diastolic blood pressure > 110 mmHg is listed as a relative contraindication of 
exercise testing in the American College of Sports Medicine guidelines 
(American College of Sports Medicine, 2016)]. However, the latest American 
College of Cardiology/American Heart Association guidelines defined the 
hypertensive crisis as systolic blood pressure > 180 mm or a diastolic blood 
pressure > 100 mmHg (Whelton & Carey, 2017). Given that exercise can 
immediately increase blood pressure, our exclusion criteria were set at a level that 
is lower than the hypertensive crisis standard; 
• Diagnosis of NYHA class I-IV heart failure; 
• Myocardial infarction in the past 6 months; 
• Recent or current angina, shortness of breath, or other symptoms suggestive of 
heart failure; 
• Diagnosed Cancer; 
• Unable to consent due to impaired cognitive function; 
• Bone fracture, joint dislocation, or joint stiffness; 
• Local skin disorders at the FES cuff area or CGM sensor area; 
• Implantable electronic or metallic devices, such as cardioverter-defibrillator and 
pacemaker; (Implantable cardioverter-defibrillator and pacemaker have been 
listed as contraindications of FES therapy). 
 
Sample Size & Power Calculations 
 
Currently, there is no published data on the acute effects of motor-assisted cycling or 
FES cycling in patients with type 2 diabetes. Therefore, the sample size of 9 participants 
in our study was determined based on the previously reported sample size (n=9 for both 
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studies) in acute exercise studies in individuals with type 2 diabetes (Manders, Van Dijk, 
& Van Loon, 2009; Larsen et al., 1997;).  
 
Screening and Familiarization 
The screening and familiarization occurred in the assisted-living centers. Participants 
who were interested in the study were able to contact our research team via phone or email. 
They were also able to contact the staff nurses in person. Screening visits were scheduled 
based on the availability of the participants. A written informed consent form was provided 
to each participant, the study procedures were explained in lay language, and any questions 
were answered. After the written consent was obtained, the participants were instructed to 
complete the screening questionnaires.  The screening questionnaires included 
demographics (e.g., age, gender, race), physical activity readiness (PARQ+), an ADL 
index, and dementia questionnaires. 
1. An ADL index questionnaire (Appendix C) was used to verify the eligibility of the 
volunteers (Katz, Downs, Cash, & Grotz, 1970).  
2. The physical activity readiness questionnaire (PARQ+) (Appendix D) was used to 
review the relevant medical history and exclude high-risk persons for exercise treatment 
(Warburton, Jamnik, Bredin, & Gledhill, 2011).  
3. A dementia screening questionnaire (Appendix E) was used to excluded persons with 
cognitive impairment (Borson, Scanlan, Chen, & Ganguli, 2003).  
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4. Demographic (age, race, and gender) and anthropometric (height, weight, and waist 
girth) measures were taken during the screening visit. Self-reported height and weight were 
used as alternatives when the measurement was not feasible (e.g., Scales for wheelchair 
users were not available).  
5. Waist girth was measured at the level of the umbilicus with readings taken at the end 
of a normal exhalation using a 150 cm tension controlled, non-stretching anthropometric 
tape (Gulick, Country Technology, Inc., Gays Mills, WI ).  
6. Resting blood pressure was measured using an automatic blood pressure monitor (5 
Series, Omron, IL).  
Participants were instructed to fast for 9 hours before the next visit (familiarization 
visit). At the end of the screening visit, we asked the participants who answered yes on one 
or more of the seven general health questions on the PARQ+ to obtain a medical clearance 
form from their health care providers for exercise. 
All enrolled participants attended a familiarization visit. The familiarization was 
scheduled at least three days before the initial experiment visit. Fasting glucose was 
measured using the finger-stick method. We verified the medical clearance with each 
participant at the beginning of the familiarization visit. If the medical clearance indicated 
that the participant could participate in our exercise interventions, we instructed the 
participant to perform 3 minutes of motor-assisted cycling and 3 minutes of FES cycling on 
a stationary bike (Reck, Betzen-Weiler, Germany) to evaluate their ability to complete the 
actual 3×10 minutes exercise treatments. During the motor-assisted cycling, the highest 
tolerable cadence was determined by increasing the cycling cadence continuously upon the 
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verbal consent from the participant until 60 rpm was reached, or the participant indicated 
that the highest tolerable cadence was reached. During the 3 minutes of FES cycling, the 
cycling cadence was matched to the motor-assisted cycling, and the highest tolerable 
amplitude of FES for each participant was determined by increasing the amplitude by one 
mA upon the verbal consent of the participant. The randomization occurred after the 
familiarization visit. During the familiarization visit, we also instructed the participants to 
refrain from consuming caffeine and alcohol and performing structured exercise 2 days 
before the study treatment. Participants were instructed to maintain their usual anti-
hyperglycemic treatment regimen.  
 
Experiment Treatments 
There were three experimental treatments. The wash-out period between treatments 
was three days (Devlin et al., 1987; Mikines et al., 1988; Wojtaszewski et al., 2000). The 
CGM sensor (FreeStyle Libre Pro, Abbott Diabetes Care, Alameda, CA) was inserted on 
the back of the upper arm at least 24 hours before the exercise experiment because the 
accuracy of the CGM is not optimal on the first day after the sensor insertion. Prior to the 
testing date, participants were instructed to consume identical dinners each night before the 
three experimental visits. The details of the first dinner were recorded. For the second and 
third dinner, reminders were sent to the participants via phone or in-person visits to ensure 
the consistency of food intake. For each exercise treatment visit, participants performed a 
total of 30 minutes of exercise. The exercise was divided into three 10-min bouts. The 
rationales of the 30-minutes exercise duration were based on two factors. First, numerous 
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studies have shown that 30-60 minutes of exercise was effective in decreasing postprandial 
glucose (Erickson et al., 2017a; Erickson et al., 2017b; Larsen et al., 1997; Van Dijk et al., 
2012; Van Dijk et al., 2013). Second, we selected the lower limit (30 minutes) of this range 
to accommodate the limited exercise capacity of this population.  
Similarly, the exercise was performed in three 10-min bouts instead of a single 30-min 
bout to accommodate this deconditioned population. This intermittent exercise pattern has 
been shown as effective in patients with diabetes (Erickson et al., 2017a). The testing 
procedures for three treatment sequences are listed below (Figure 2): 
 
1. Testing Procedures with Sequence ABC 
A. Motor-assisted Cycling Treatment 
The intervention and control treatments took place in the retirement community in the 
morning. Fasting glucose was measured using the finger-prick method. The breakfast and 
exercise treatment was not started if the fasting glucose was ≥250 gm/dL, and the treatment 
had to be rescheduled. At 7:30 AM, participants were provided with a standardized 
breakfast, which was consumed within 15 minutes. After the completion of the breakfast, 
participants remained seated for 15 minutes.  
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After the 15 minutes of waiting time, participants started to perform the motor-assisted 
cycling exercise using a physical therapy bike (RECK; Betzenweiler, Germany). 
Participants performed 3×10-min bouts of motor-assisted cycling. Before each bout, 
participants performed 1-2 minutes of motor-assisted cycling at 5-10 rpm as a warm-up. 
Each bout lasted 10 minutes, and the rest period between bouts was 5 minutes. The 
cadence was gradually increased to the highest tolerable level during the first 1-2 minutes 
and maintained at the same level throughout the exercise bout. We instructed the 
participants to remain relaxed and avoid volitional muscle contractions during the motor-
assisted cycling.  
After three bouts, participants performed 1-2 minutes of motor-assisted cycling at 5-10 
rpm as a cool-down. Participants remained seated after the completion of the exercise 
protocols until the 2-hour postprandial period was concluded.  
Heart rate, the rating of perceived exertion (RPE), and blood pressure were monitored 
before, during, and after the exercise treatment. Heart rate was measured every minute 
using a Polar heart rate monitor (Polar Vantage M Monitors, Polar Electro Inc. NY, USA) 
placed on the index finger. Blood pressure was taken every 5 minutes on the right arm with 
a manual sphygmomanometer (Aneroid Sphygmomanometer, American Diagnostic 
Corporation) with the participant in a sitting position. The RPE was measured every minute 
by having the participant point at the corresponding level on the 6-20 Borg RPE scale 
(Borg, 1998). Instructions for the RPE table was provided to the participant before the 
measure.  
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For the remaining time of the experiment day, participants were instructed to refrain 
from any purposeful exercise or physical activity except activities of daily living. They 
were also instructed to maintain the same diet on the three experimental days.  
 
B. FES Cycling Treatment 
The testing procedures were identical to that in the motor-assisted cycling treatment 
except for the exercise type. 
The FES cycling was performed on the motor-assisted bike, and the participants were 
wearing the wearable FES equipment during the whole cycling treatment. The purpose of 
the motor-assisted cycling was to provide a constant cadence. The Bioness L300 Plus 
system (Bioness, Valencia, CA) was worn on the upper and lower legs to stimulate the 
quadriceps and anterior tibialis muscles during the motor-driven cycling exercise. An 
embedded gyroscope of the cuff can detect the motion of the lower leg so that the electrical 
stimulations were generated at the appropriate timing to activate leg muscles during the 
cycling exercise. The FES amplitude of our equipment ranged from 1 to 100 mA. The FES 
amplitude for each participant was determined based on the highest FES amplitude 
achieved during the familiarization visit. The FES frequency was 40 Hz; the duration of a 
single stimulus was 300 μS. The crank angle for the quadriceps activation was from 345° to 
165° and was from 165° to 345° for the tibialis anterior. 
Before each FES cycling bout, participants performed 1-2 minutes of motor-assisted 
cycling without FES activation as a warm-up. Participants performed 3×10-min bouts of 
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FES cycling. Each bout lasted 10 minutes, and there was a 5-minute rest between bouts. 
The intensity of FES was increased gradually to the maximum tolerable level of each 
participant. The FES cycling procedures were supervised by a board-certified physical 
therapist. After three bouts, participants performed 1-2 minutes of motor-assisted cycling 
without FES as a cool-down. 
C. Control. 
During the control treatment, participants consumed the same breakfast and remained 
seated for the 2-h postprandial period. The participants were free to watch TV or read 
books during this period.  
2. Testing Procedures with Sequence BCA 
The participants attended the three treatments in this order: FES cycling (B); control 
(C); and motor-assisted cycling (A). The protocols for each treatment was identical to that 
in sequence ABC. 
3. Testing Procedures with Sequence CAB 
The participants attended the three treatments in this order: control (C); motor-assisted 
cycling (A); and FES cycling (B). The protocols for each treatment will be identical to that 
in sequence ABC. 
 
Continuous Glucose Monitoring (CGM) and AUC Calculation 
The CGM sensor (FreeStyle Libre Pro, Abbott Diabetes Care, Alameda, CA) was 
inserted on the back of the upper arm at least 24 hours before the experiment day because 
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of the accuracy of the CGM is not optimal on the first day after the sensor insertion. The 
sensor was removed 24 hours after the experiment day. The interstitial glucose values were 
recorded continuously every 15 minutes throughout the study period. Glucose data were 
downloaded using a Bluetooth reader after the removal of the sensor. Glucose values at 
each time point were exported into an excel file using the CGM online program 
(https://www2.libreview.com). Baseline glucose was determined based on the timing of 
meal consumption. Postprandial 2-hour glucose AUC was calculated using the trapezoidal 
method (Chiou, 1978). The formulas for AUC and iAUC calculation are shown in 
Equation 1 and Equation 2. 
AUC = (glucose@0min+glucose@15min)
2
× 0.25 hours + (glucose@15min+glucose@30min)
2
×
0.25 hours ∙∙∙ + (glucose@105min+glucose@120min)
2
× 0.25 hours              (1) 
iAUC = AUC − glucose@0min × 2 hours                              (2)  
The accuracy of the Libre Pro CGM sensor has been validated in a study of 72 patients 
with diabetes (59 had type 1 diabetes, and 13 had type 2 diabetes) (Bailey, Bode, 
Christiansen, Klaff, & Alva, 2015). The correlation coefficient between the CGM and the 
capillary glucose was 0.95. The mean absolute relative difference between CGM values 
and venous glucose values was 12%, indicating that the average discrepancy between the 
two methods was about 12%. The accuracy of the CGM was not influenced by patients’ 
characteristics, including age, BMI, glycemic control, and types of diabetes. On the other 
hand, using finger-stick capillary glucose meters to measure glucose levels is subject to the 
skill of the user. The accuracy of stick capillary glucose meters varies greatly in the 
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literature (Bergenstal, 2008). The FDA criteria for approving capillary glucose meters is ± 
20 mg/dL or ± 20% compared to the reference values (Food and Drug Administration, 
2014). A study reported that the discrepancy between the capillary glucose meter values 
and the venous values was up to 20-25% (Farrer et al., 1995). 
Statistical Analysis 
Assumptions for Gaussian distributions were tested using the Shapiro-Wilk tests. 
Linear mixed models (LMM) with Bonferroni post-hoc tests were used to test the mean 
differences for postprandial glucose, estimated by the AUC and iAUC, between 
intervention and control treatments after adjustment for covariates (e.g., age, sex, and 
race). Cohen’s d was used to compute the effect size (ES) between intervention and 
control treatments. Paired t-tests were used to compare the change in mean difference for 
heart rates, systolic and diastolic blood pressures across between sitting control and 
motor-assisted cycling, and between sitting control and FES cycling. All statistical 
analyses were performed using Statistical Analysis Systems software, version 9.4 (SAS 
Inc., Cary, NC) and the IBM Statistical Package for Social Sciences, version 25 (SPSS, 
Armonk, NY). All P values were 2-sided, and 95% CIs were considered to indicate 
statistical significance.  
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CHAPTER 4 
RESULTS 
In this study, nine participants (2 males, 7 females) completed all three 
experimental treatments. There were no dropouts after randomization. The baseline 
characteristics of the study participants (mean ± SD) are shown in Table 1. The average 
duration of being diagnosed with diabetes was 19.3 years. The height and weight were 
based on self-reported values because all the participants were wheelchair users, and 
obtaining measured values were not feasible in our study. The average ADL score was 
three on the 6-item scale, indicating that the participants in this study were only able to 
perform, on average, 3 ADL tasks out of the 6 ADL tasks on the scale (Katz et al., 1970). 
The most prevalent ADL disability was transferring disability. Of the nine participants, 
seven reported that they needed some help with transferring between bed and chair. All 
participants were diagnosed with type 2 diabetes by their healthcare providers. This 
information was verified by the staff nurses in the assisted-living centers. Two 
participants were using metformin monotherapy for the management of type 2 diabetes. 
Seven participants were using metformin plus second-line glucose-lowering medications, 
including glucagon-like peptide 1 receptor agonist (n=2), sulfonylurea (n=3), and 
dipeptidyl peptidase 4 inhibitor (n=2). Of the nine participants, eight patients have been 
diagnosed with diabetic neuropathy; four patients have had one or more ischemic strokes; 
three patients have been diagnosed with stable coronary heart disease. 
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Table 1 
Baseline Characteristics of Study Participants* 
 
Variables Mean ± SD 
Age (years) 79.0 ± 10.5 
Height (cm) 163.0 ± 7.5 
Weight (kg) 78.9 ± 17.9 
Body Mass-Index (kg/m2) 29.8 ± 6.9 
Waist circumference (cm) 99.6 ± 16.6 
Systolic blood pressure (mmHg) 136.9 ± 17.5 
Diastolic blood pressure (mmHg) 70.0 ± 8.8 
Fasting blood glucose (mmol/L) 6.9 ± 0.9 
HbA1c % 6.8 ± 0.8 
Type 2 Diabetes Duration (years) 19.3 ± 12.9 
ADL Disability Score† 3.1 ± 1.2 
Most prevalent ADL disability Transferring Disability 
Notes. *Values represent mean ± SD. †The ADL disability score ranges from 0-6, with 6 indicates 
no ADL disability, and 0 indicates all 6 ADL disabilities.  
 
The mean scores for the cycling cadence, FES amplitude, and RPE are shown in 
Table 2. The cycling cadence was consistent between the motor-assisted cycling and FES 
cycling treatments. During each cycling treatment, the cycling cadence remained at the 
same level for the three bouts of exercise. The average RPE score in the FES cycling 
treatment was higher by one than during the motor-assisted cycling treatment (p=0.045). 
Six participants showed noticeably different tolerance levels between the four skin areas 
of cuff placement. Due to these differences, we applied variable FES amplitude according 
to the tolerance level at the specific skin areas. For the other three participants, the FES 
stimulus intensity was the same across all four cuffs. Overall, the FES amplitude was 
higher in the thigh cuffs than in the lower leg cuffs (Table 2). 
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Table 2. 
Summary of Cycling Cadence, FES Stimuli Intensity, and RPE٭  
Notes. ٭Values represent mean ± SD.  
 
Table 3 presents cardiovascular responses from motor-assisted cycling and FES 
cycling. As shown in Table 3, the exercising heart rate was significantly higher during the 
motor-assisted cycling (p = 0.011) and the FES cycling (p = 0.045), as compared with 
sitting control. An increase in the systolic blood pressure was observed during the FES 
cycling (p = 0.015), but not during the motor-assisted cycling (p = 0.19), as compared to 
control. Neither motor-assisted cycling (p= 0.09) nor FES cycling (p=1.0) had noticeable 
effects on the diastolic blood pressure responses.  
Table 3.  
Cardiovascular Responses to Motor-assisted Cycling and FES Cycling٭  
 
Variables Sitting 
Control 
Motor-assisted 
Cycling (MC) 
   FES 
Cycling 
Control 
vs MC 
Control 
vs FES 
Heart Rate 70.9 ± 7.1 7.7 ± 8.4 74.6 ± 7.4 0.011 0.045 
Systolic Blood 
Pressure 
137.2 ± 17.8 140.6 ± 17.1 144.0 ± 20.3 0.19 0.015 
Diastolic Blood 
Pressure 
70.2 ± 8.6 73.7 ± 9.9 69.8 ± 8.9 0.09 1.00 
 
Notes. ٭Values represent mean ± SD.  
Variables  
Motor-assisted cycling cadence (revolutions per minute) 39.2 ± 12.6 
FES cycling cadence (revolutions per minute) 39.2 ± 12.6 
RPE during Motor-assisted cycling 10.0 ± 0.8 
RPE during FES Cycling 10.8 ± 1.5 
FES Amplitude Average of Four Cuffs (mA) 27.2 ± 6.9 
FES Amplitude Left Thigh (mA) 25.1 ± 7.8 
FES Amplitude Right Thigh (mA) 25.6 ± 7.6 
FES Amplitude Left Lower Leg (mA) 28.8 ± 6.8 
FES Amplitude Right Lower Leg (mA) 29.3 ± 7.2 
FES Frequency (Hz) 40.0 
FES Duration of a Single Stimulus (mS) 0.3 
Interphase Duration (μS) 50.0 
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Table 4 summarized the 2-h postprandial glucose AUC and iAUC values and the 
24-h average glucose levels in the three experimental conditions. There were no 
statistical differences in random effect in both AUC (p = 0.53) and iAUC (p = 0.73).  As 
shown in Table 4 and Figures 3A-3B, the 2-h postprandial glucose AUC and iAUC were 
significantly different across two interventions and one control treatments (AUC, p = 
0.038; iAUC, p = 0.005). FES cycling resulted in a lower mean of 2-hour postprandial 
iAUC as compared with sitting control (iAUC 3.98 mmol∙h/L vs 6.92 mmol∙h/L, p = 
0.006, ES = 1.72) and the motor-assisted cycling (iAUC, 3.98 mmol∙h/L vs 6.19 
mmol∙h/L , p = 0.0368, ES = 1.29), respectively. The FES cycling also resulted in a lower 
mean of the 2-hour postprandial AUC as compared with sitting control (AUC, 18.29 
mmol∙h/L vs 20.95 mmol∙h/L, p = 0.043, ES = 0.89), but had AUC similar to the motor-
assisted cycling (18.29 mmol∙h/L vs 20.23 mmol∙h/L , p = 0.183, ES = 0.19).  There were 
no statistical differences in iAUC (6.19 mmol∙h/L vs 6.92 mmol∙h/L) and AUC (20.23 
mmol∙h/L vs 20.95 mmol∙h/L) between the motor-assisted cycling and sitting control (all 
p = 1.0).  There were no statistical differences for the 24-h average glucose levels across 
FES cycling, motor-assisted cycling, and control treatments (p = 0.306) as shown in 
Table 4 and Figure 4.   
 
 
60 
 
 
Figure 3A shows the 2-h glucose levels from continuous glucose monitoring 
across motor-assisted cycling, control, and FES cycling after breakfast consumption (p = 
0.038). Figure 3B shows the 2-h postprandial iAUC responses across motor-assisted 
cycling FES cycling, and control after breakfast consumption (p=0.005). Glucose levels 
were recorded every 15 minutes.   
 
 
 
Variables Motor-assisted 
Cycling (MC) 
FES Cycling Siting 
Control 
P-value† 
2-h AUC 
(mmol∙h/L) 
20.23 ± 3.38 18.29 ± 2.80 20.84 ± 2.92 Fixed Effect          
MC vs Control 
FES vs Control 
FES vs MC 
0.038 
1.00 
0.043 
0.183 
2-h iAUC 
(mmol∙h/L) 
6.19 ± 2.56 3.98 ± 1.36 6.92 ± 2.00 Fixed Effect          
MC vs Control 
FES vs Control 
FES vs MC 
0.005 
1.00 
0.006 
0.037 
24-h 
Average 
(mmol/L) 
7.01 ± 1.00 7.21 ± 1.40 7.38 ± 1.49 Fixed Effect          
MC vs Control 
FES vs Control 
FES vs MC 
0.306 
0.39 
1.00 
1.00 
Table 4.  
Blood Glucose Responses across Motor-assisted Cycling (MC), Sitting Control, and 
FES Cycling in Type 2 Diabetic Patients with ADL Disability٭ 
Notes. ٭Values (mean ± SD) adjusted for age, sex, and race. †Bonferroni post-hoc 
comparisons across MC, sitting control, and FES cycling treatments.  
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Figure 4 shows the 24-h glucose levels from the continuous glucose monitoring 
across motor-assisted and FES cycling and control treatments (p = 0.306). Glucose levels 
were recorded every 15 minutes.  
 
Figure 3B. The 2-h postprandial iAUC responses across motor-assisted cycling, FES cycling, and 
control after breakfast consumption.  *Mean difference between FES and motor-assisted cycling 
(p = 0.037).†Mean difference between FES and sitting control (p = 0.006). 
Figure 3A. The 2-h postprandial glucose responses across motor-assisted cycling, FES 
cycling, and control after breakfast consumption. 
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Figure 4. The 24-h glucose responses by motor-assisted cycling, FES cycling, and control following 
breakfast consumption.  
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Chapter 5 
DISCUSSION 
Effective glucose management using exercise modalities in older patients with 
diabetes and ADL disabilities are unknown. Our major finding was that performing 30 
minutes of FES cycling (40 Hz, 39 rpm, 25-29 mA) on a motor-assisted bike significantly 
decreased 2-h postprandial blood glucose levels in older adults with type 2 diabetes and 
ADL disabilities. Significant glucose reductions were seen in postprandial 2-h AUC and 
2-h iAUC. The FES cycling protocols were well tolerated in all participants. To our 
knowledge, this is the first study to investigate the beneficial effect of FES cycling on 
blood glucose levels in such patients.  
Our findings in FES cycling are consistent with the metabolic effects noted in 
patients with SCI (Harness & Astorino, 2011; Hooker, Scremin, Mutton, Kunkel, & 
Cagle, 1995; Hunt et al., 2006; Norton, Norton, & Sadgrove, 2010). Hunt et al. (2006) 
observed that energy expenditure is increased by 2 to 2.5 times during FES cycling 
compared to the baseline resting energy expenditure in a single participant with 
paraplegia. Hunt et al. (2006) used the cycling cadence of 50 rpm using an electric motor, 
and the FES electrodes placing on the skin surface of the quadriceps, hamstring, and 
gluteal muscles with the frequency of the electrical stimuli of 20 Hz and an amplitude 
ranging from 90-120 mA. Harness & Astorino (2011) also reported that the FES cycling 
(33.3 Hz, 45 rpm, 140 mA) significantly increased the energy expenditure to 2.5 times as 
high as the resting energy expenditure in patients with tetraplegia. Harness & Astorino 
(2011) stimulated muscles during their FES protocols, including the gluteus maximus, 
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hamstrings, and quadriceps. Some investigators (Norton, Norton, & Sadgrove, 2010) 
have demonstrated that FES cycling can achieve an energy expenditure equivalent to the 
voluntary exercise of 2.5 SCI METs, which is similar to light-intensity exercise.  Few 
investigators have also shown that FES cycling induced high metabolic responses in 
patients with SCI (Hooker et al., 1995). Hooker et al. (1995) showed that steady-state 
oxygen consumption was 12.3 ml/kg/min (4.5 SCI METs) during FES cycling (30 Hz, 50 
rpm, up to 132 mA), which is similar to the moderate-intensity voluntary exercise 
(Haskell et al., 2007). Notably, one MET in SCI patients is equal to 2.7 ml/kg/min in SCI 
patients due to the loss of muscle mass and long-term inactivity (Bauman & Spungen, 
2000; Collins et al., 2010).   
Our findings in the beneficial effect of FES cycling on glucose responses are also 
consistent with the results from other short-term studies in patients with SCI (Griffin et 
al., 2009; Jeon et al., 2002). Griffin at al. (2009) showed that a 10-week of FES training 
significantly lowered the postprandial glucose levels at 30, 60, and 120 min in 18 patients 
with SCI. Similarly, Jeon et al. (2002) reported that eight weeks of FES cycling increased 
peripheral glucose uptake in patients with SCI, as measured by the hyperglycemic clamp 
test.  
There has been limited research on testing the effect of motor-assisted cycling on 
postprandial glucose response in patients with type 2 diabetes and ADL disability. 
Interestingly, our results indicate that 30 minutes of motor-assisted cycling did not 
improve postprandial glucose levels in older patients with type 2 diabetes and ADL 
disability. Our finding was consistent with ill patients, but not for healthy individuals. 
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Pires-Neto et al. (2013) demonstrated that 20 minutes of motor-assisted cycling at 30 rpm 
did not induce significant changes in energy expenditure in critically ill patients. 
However, Peterman et al. (2016) reported a glucose-lowering effect of motor-assisted 
cycling in healthy individuals. According to Peterman et al. (2016), 30 minutes of motor-
assisted cycling at 80 rpm significantly decreased 2-h glucose in healthy participants. 
Notably, the cycling cadence in the Peterman et al. (2016) was more than two times 
higher than in our study (80 rpm vs. 39 rpm). Our null findings in motor-assisted cycling 
on glucose responses compared with sitting control may be due to the substantial 
difference in cycling cadence. Peterman et al. (2012) have shown a positive association 
between the cadence of the motor-assisted cycling and energy expenditure, indicating that 
a higher cycling cadence was a critical factor for eliciting metabolic benefits during 
motor-assisted cycling. Our findings using passive cycling at a cadence of 39 rpm was 
not sufficient to induce significant glucose change among older patients with type 2 
diabetes with ADL disabilities.  
The slow cycling cadence in motor-assisted cycling was seemingly the main 
reason for the absence of a significant effect on glucose response. Our findings provided 
meaningful information on the application of motor-assisted cycling in patients with 
diabetes and ADL disability. The slow cycling cadence reflected the greatly limited 
exercise ability of the participants. Indeed, the average age of the participants was 79 
years. They were experiencing substantial difficulties in performing activities of daily 
living, such as transferring from bed to chair. Although we encouraged each participant 
to achieve their highest tolerable cycling cadence, only two participants were able to 
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exercise at a cadence of 60 rpm while four participants exercised at a cadence ≤ 30 rpm. 
Our findings suggested that the participants’ ability to perform motor-assisted cycling 
exercise was greatly limited. The feasibility of achieving a higher motor-assisted cycling 
cadence in this frail population needs further investigation. 
It is plausible that FES cycling may enhance glycemic control in patients with 
diabetes and ADL disability.  Our study provides new insight into the mechanism 
underlying the glucose-lowering effect of FES cycling on a motor-assisted bike. In our 
study, the FES cycling protocols comprised the motor-assisted cycling component and 
the electrical stimulation component. The primary mechanism responsible for the 
glucose-lowering effect of FES cycling was the electrical stimulation component rather 
than the motor-assisted cycling component, in which the motor-assisted cycling showed 
non-significant glucose change. Because the cycling cadence in our study was identical 
between the FES cycling and the motor-assisted cycling, the motor-assisted cycling 
component in the FES cycling should have induced a similar effect on postprandial 
glucose changes as compared to the motor-assisted cycling treatment. Nonetheless, the 
reduction in 2-h AUC in the motor-assisted cycling was only 0.61 mmol∙h/L, while the 
reduction in FES cycling condition was 2.55 mmol∙h/L, compared with sitting control, 
indicating the motor-assisted cycling component was not responsible for the glucose 
changes in the FES cycling treatment.  
Considerable evidence indicates that patients using FES devices without cycling 
movement stimulates skeletal muscle glucose uptake (Hamada, Hayashi, Kimura, Nakao, 
& Moritani, 2004; Hamada, Sasaki, Hayashi, Moritani, & Nakao 2003). Hamada and 
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colleagues (2004) have shown that electrical stimulation of the leg muscles during 
isometric contractions (i.e., not combined with cycling movement) significantly increased 
whole-body glucose disposal rate among healthy participants, suggesting a potential 
glucose-lowering effect of electrical stimulation. Moreover, Gorgey and colleagues 
(2017) have shown that 16 weeks of FES cycling increased the content of GLUT-4 in leg 
muscles by 3.8 folds among participants with SCI, suggesting similar molecular adaptive 
responses to FES cycling, as compared with traditional exercise (Richter & Hargreaves, 
2013).   
The FES cycling speed in our study was lower compared with other studies in 
patients with SCI (39 rpm vs. 50 rpm) (Hooker et al.,1995; Hunt et al., 2006). We assume 
that the lower cycling cadence would not affect the FES cycling intensity. For instance, a 
previous study showed that FES cycling at 15, 30, and 50 rpm resulted in similar 
increases in energy expenditure despite the substantial differences in cycling cadence 
(Fornusek & Davis, 2008), suggesting cycling speed was not a determining fact of FEC 
cycling intensity. Our study used a similar FES frequency (40 Hz) and a duration of every 
single pulse (0.3 ms) compared to previous studies (Hooker et al.,1995; Hunt et al., 
2006). However, the FES amplitude was much lower in our study (26 mA vs. 90-140 mA 
in SCI patients) compared with the previous FES cycling studies in patients with SCI 
(Hooker et al., 1995). We used a lower FES amplitude because individuals without SCI 
may not be able to tolerate the discomfort of a high FES amplitude (Delitto, Strube, 
Shulman, & Minor, 1992). Some investigators have shown that FES cycling at an 
amplitude of 50-60 mA was sufficient to increase the energy expenditure by 2.5 times 
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(Hunt, Hosmann, Grob, & Saengsuwan, 2013). Other investigators have also reported 
that the FES cycling with a lower FES amplitude (25-46 mA) can achieve an exercise 
intensity that was equivalent to volitional exercise at 1.4 METs or 25 watts in healthy 
persons (Gojda et al., 2019), which is similar to very light-intensity exercise (Haskell et 
al., 2007; Norton et al., 2010). In addition, the RPE level (11±1) during FES cycling also 
indicates a light-intensity exercise. Thus, we believe that the FES cycling intensity in our 
study was similar to either light or very light-intensity volitional exercise. Importantly, 
light-intensity and very light-intensity exercise have been shown as effective in lowering 
postprandial glucose levels in individuals with and without diabetes (Aadland & 
Høstmark, 2008; Dempsey et al., 2016; Høstmark et al., 2006; Lunde, Hjellset, & 
Høstmark, 2012; Van Dijk et al., 2013).  
The 24-h average glucose values were not significantly different across the three 
conditions. Our finding is consistent with previous findings that 45 minutes of light 
activities were not effective in reducing 24-hour glucose (Van Dijk et al., 2013). Because 
the 24-h glucose levels in our study were measured in a free-living condition, our 
findings regarding the 24-h glucose should be interpreted with caution. 
Our findings revealed that the motor-assisted cycling had minimal effects on the 
cardiovascular system. We did not observe significant changes in systolic and diastolic 
blood pressure during the motor-assisted cycling. Although the heart rate difference 
between the motor-assisted cycling and sitting control was statistically significant, the 
mean heart rate difference was only four bpm. These findings were in agreement with 
previous studies that observed heart rate and blood pressure during passive cycling had 
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slight changes or stayed largely at resting state (Muraki & Tsunawake, 2008; Ter Woerds, 
De Groot, Van Kuppevelt, & Hopman, 2006). In the FES cycling treatment, we found a 
significant increase in the systolic blood pressure, but not in the diastolic pressure, which 
is consistent with other FES cycling studies (Faghri, Glaser, & Figoni, 1992; Fornusek & 
Davis, 2008). The increased systolic blood pressure was due to the neural feedback from 
the working muscles (McCloskey & Mitchell, 1972), while the unchanged diastolic blood 
pressure may be due to the metabolites-induced vasodilation at the stimulated limbs 
(Honig, 1979). The heart rate change during FES cycling in our study was only four bpm, 
while previous studies have reported a heart rate increase of approximately 20 to 35 rpm 
during FES cycling (Fornusek & Davis, 2008; Raymond, Davis, & Van Der Plas, 2002). 
We speculate that the lower FES stimulation amplitude may be responsible for the 
modest heart rate increase in our study.  
The absence of a heart rate change has also been consistently reported in motor-
assisted cycling studies. A study examined the effect of a 4-week of FES cycling training 
program and did not show statistically significant improvement of resting heart rate and 
blood pressure in subacute stroke patients (Lee et al., 2013). Thus, the heart rate 
measurement cannot be used to interpret the exercise intensity in our study. The 
exercising heart rate and blood pressure mainly served as safety measurements for 
monitoring cardiovascular responses to the treatments.  
A strength of this study is that we used the CGM system in this population, which 
allows frequent measures of glucose levels throughout the experiment period with 
minimal burden on the participant. Another strength of this study is that our data were 
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obtained using a randomized control trial in diabetic patients with lower-extremity 
disability. A limitation of this study is that we only measured the acute responses of 
glucose to the exercise treatments. Further research should investigate the long-term 
efficacy and safety of the proposed exercise treatments in this population. Our study is 
also limited to Caucasian subjects with small sample size. Further research should recruit 
a sufficient sample size across different races and sex groups. Our post hoc power 
analysis shows that a sample size of 9 had approximately 71% of power (2-sided, alpha = 
0.05) to detect 2.55 mmol∙h/L (2-h AUC) difference between FES and sitting control in a 
3 x 3 cross-over study design.   
Our findings have potentially important clinical relevance because we provided 
the first evidence regarding the preliminary efficacy of FES on glucose levels in persons 
with diabetes, a large and fast-growing population (Guariguata et al., 2014). To date, FES 
cycling has been primarily used in patients with spinal cord injuries for preserving the 
muscle mass and improving physical function. The application of FES cycling has not 
been widely tested in persons without SCI, partially due to the concern of the painful 
electrical stimulation during FES cycling (Delitto et al., 1992). The FES equipment used 
in our study minimized the pain sensation through two methods. First, we used larger 
electrode pads (543 cm2 in our study vs. less than 50 cm2 in previous studies) (Bajd and 
Munih, 2010), which has been suggested to be effective in decreasing the unpleasant 
sensation in the contact areas (Bajd and Munih, 2010). Another advantage of using larger 
electrodes is that they are more suitable and effective for large muscle groups, such as the 
quadriceps (Bajd and Munih, 2010). Second, we minimized the FES discomfort by 
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individualizing the FES amplitude according to the tolerance level of each participant in 
our study. During the familiarization visit, we increased the FES amplitude by 1 mV each 
time after the participant confirmed that the intensity was tolerable. Additionally, the FES 
amplitude for each cuff was managed separately because the pain sensation can differ 
greatly between different skin locations due to diabetic neuropathy (Brown & Asbury, 
1984). In our study, the average FES amplitude was 4 mA higher in the lower leg cuffs 
than in the thigh cuffs. The higher FES amplitude in the lower leg cuffs may be due to the 
severer sensory diabetic neuropathy in the distal part of the limbs and the reduced 
impaired pain perception (Pop-Busui et al., 2017). There was no difference in FES 
amplitudes between legs, suggesting a symmetrical distal sensory loss, which agrees with 
the current knowledge (Pop-Busui et al., 2017).   
The current diabetes care guidelines recommend promoting physical activity and 
exercise across the lifespan, including various populations and older adults. However, 
specific and practical exercise recommendations for older adults who have difficulties 
performing traditional exercises are less clear. Our findings showed preliminary evidence 
that FES cycling could be an effective and safe exercise modality to improve glucose 
management. Our study has important clinical implications for improving diabetes care 
among the frail and fast-growing older adult populations with long-standing diabetes and 
impaired physical function.    
Our findings suggested that 30 minutes of FES cycling (40 Hz, 39 rpm, 25-29 
mA) can be a promising method for blood glucose management in patients with type 2 
diabetes who have difficulties in performing a traditional exercise. Public health agencies 
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and clinicians should emphasize the importance of using FES cycling for glycemic 
control in type 2 diabetic patients with ADL disability.   
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